Literature DB >> 3344543

Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals.

H Lechner1, R Schmidt, G Bertha, E Justich, H Offenbacher, G Schneider.   

Abstract

The incidence, average number, and localization of lesions of the white matter detected by the T2-weighted nuclear magnetic resonance images among volunteers without cerebrovascular symptoms have been correlated with the number of risk factors for stroke. Accepted risk factors were arterial hypertension, diabetes mellitus, smoking, hypercholesterolemia, and cardiac disease. The 42 subjects examined were divided into Group A (0-1 risk factor, mean age 59.36 +/- 5.73 years), Group B (2 risk factors, mean age 61.54 +/- 8.33 years), and Group C (greater than or equal to 3 risk factors, mean age 62.57 +/- 9.83 years). Multiple risk factors among the age-matched groups was accompanied by a highly significant increase (p less than 0.001, Group A versus Group B; p less than 0.01, Group A versus Group C) of the incidence of white matter lesions. The average number of white matter lesions was increased (p less than 0.001) when Group A was compared with Groups B and C. Ninety-two percent of the white matter lesions were localized in watershed zones. Only 11 of the 155 abnormalities of the white matter detected by nuclear magnetic resonance imaging could be detected by computed tomography. White matter lesions in T2-weighted images appear to be an early stage of cerebrovascular disease.

Entities:  

Mesh:

Year:  1988        PMID: 3344543     DOI: 10.1161/01.str.19.2.263

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Periventricular white matter changes and oropharyngeal swallowing in normal individuals.

Authors:  R Levine; J A Robbins; A Maser
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438

2.  Neurological long term consequences of deep diving.

Authors:  K Todnem; H Nyland; H Skeidsvoll; R Svihus; P Rinck; B K Kambestad; T Riise; J A Aarli
Journal:  Br J Ind Med       Date:  1991-04

3.  Neuropsychological studies of blacks with cerebrovascular disorders: a preliminary investigation.

Authors:  A Brown; A Campbell; D Wood; A Hastings; O Lewis-Jack; G Dennis; P Ford-Booker; L Hicks; A Adeshoye; R Weir
Journal:  J Natl Med Assoc       Date:  1991-03       Impact factor: 1.798

4.  Cranial MRI and CT in patients with left atrial myxoma.

Authors:  E Hofmann; T Becker; R Romberg-Hahnloser; H Reichmann; M Warmuth-Metz; M Nadjmi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

5.  Multiple high intensity lesions considered as "état criblé".

Authors:  Y Matsukawa; S Nishinarita; T Horie; S Kimura
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

6.  Pathological correlates of white matter hyperintensities on magnetic resonance imaging.

Authors:  Yong Soo Shim; Dong-Won Yang; Catherine M Roe; Mary A Coats; Tammie L Benzinger; Chengjie Xiong; James E Galvin; Nigel J Cairns; John C Morris
Journal:  Dement Geriatr Cogn Disord       Date:  2014-11-08       Impact factor: 2.959

Review 7.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  MRI of the brain in diabetes mellitus.

Authors:  Y Araki; M Nomura; H Tanaka; H Yamamoto; T Yamamoto; I Tsukaguchi; H Nakamura
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

9.  Grading white matter lesions on CT and MRI: a simple scale.

Authors:  J C van Swieten; A Hijdra; P J Koudstaal; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

10.  Periventricular hyperintensity on magnetic resonance imaging correlated with brain ageing and atrophy.

Authors:  K Meguro; T Yamaguchi; T Hishinuma; H Miyazawa; S Ono; K Yamada; T Matsuzawa
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.